Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics.
about
Sialic acid modification of adiponectin is not required for multimerization or secretion but determines half-life in circulationCirculating adiponectin levels in various malignancies: an updated meta-analysis of 107 studiesEndothelial dysfunction in cirrhosis: Role of inflammation and oxidative stressCytokinome profile of patients with type 2 diabetes and/or chronic hepatitis C infectionAdiponectin through its biphasic serum level is a useful biomarker during transition from diastolic dysfunction to systolic dysfunction - an experimental study.Obesity as the common soil of non-alcoholic fatty liver disease and diabetes: Role of adipokines.Quantitative loci regulating plasma levels of gamma glutamyl transferase and albumin and their genetic correlations with cardiovascular risk factors.Reduction of insulin resistance with effective clearance of hepatitis C infection: results from the HALT-C trialSerum adipokine and inflammatory markers before and after liver transplantation in recipients with major cardiovascular eventsCirculating adipokines in children with nonalcoholic fatty liver disease: possible noninvasive diagnostic markersSerum adiponectin and transient elastography as non-invasive markers for postoperative biliary atresiaTotal and high molecular weight adiponectin and hepatocellular carcinoma with HCV infection.Study of adiponectin in chronic liver disease and cholestasis.Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development.Serum adiponectin is associated with worsened overall survival in a prospective cohort of hepatocellular carcinoma patientsLiver function parameters in hip fracture patients: relations to age, adipokines, comorbidities and outcomes.Adiponectin, a key adipokine in obesity related liver diseasesAdiponectin reduces hepatic stellate cell migration by promoting tissue inhibitor of metalloproteinase-1 (TIMP-1) secretion.Adipokines levels are associated with the severity of liver disease in patients with alcoholic cirrhosisAdiponectin is associated with poor prognosis in carcinoma patients: evidence from a meta-analysis.Adiponectin action: a combination of endocrine and autocrine/paracrine effects.Adiponectin: action, regulation and association to insulin sensitivity.The evolving role of leptin and adiponectin in chronic liver diseases.Low Plasma Levels of Adiponectin Do Not Explain Acute Respiratory Distress Syndrome Risk: a Prospective Cohort Study of Patients with Severe Sepsis.Bioconjugation of oligonucleotides for treating liver fibrosis.Adiponectin and its receptors in chronic hepatitis B patients with steatosis in china.Ratiometric Measurements of Adiponectin by Mass Spectrometry in Bottlenose Dolphins (Tursiops truncatus) with Iron Overload Reveal an Association with Insulin Resistance and GlucagonHigh serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infection.Plasma adiponectin level and myocardial infarction: the JMS Cohort Study.Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease.Adipokines in Liver Cirrhosis.Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection.Serum adiponectin in chronic hepatitis C and B.Hepatic fat loss in advanced nonalcoholic steatohepatitis: are alterations in serum adiponectin the cause?Adiponectin, bile acids, and burnt-out nonalcoholic steatohepatitis: new light on an old paradox.Ageing and plasma adiponectin concentration in apparently healthy males and females.Elevated plasma adiponectin concentrations in patients with liver cirrhosis correlate with plasma insulin levels.Adiponectin is associated with serum and adipose tissue fatty acid composition in rats.Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.Adiponectin levels among patients with chronic hepatitis B and C infections and in response to IFN-alpha therapy.
P2860
Q24310524-EDA6C000-2926-4873-9A12-502CBC020805Q26749399-B88587F8-67B3-4408-A0D6-5F83F02A30F9Q27023122-D0FC3A11-37A4-42AD-AE1E-C1CF2751EABFQ28480545-9B6ECCBA-1AF9-4D43-917C-8E6DC58293D0Q30461204-9AD82013-59F8-47D2-95BA-57F3271BA650Q33628222-2D8D3AFF-FAA4-4D08-BC25-C0A66E1363E7Q33706798-5DBCC378-8336-4172-AFED-8498A80B0386Q33798375-E3ECD992-B1E0-468E-8FDD-8CEABE2B9268Q33812634-D06C2375-D063-4A76-A119-B3CF7D87021BQ33822990-5442D27D-466D-42F7-B1E6-B2DAA6A036B5Q33831119-E0D51ADA-D008-450D-9D90-2ACBCFD847EFQ34081435-1727F323-1679-474C-8A34-FBC60A7DFEE6Q34365487-0222BB67-619F-4578-86E7-3E126089D909Q34589677-E6BDA11F-E277-4C1F-B355-8A373B3A6DE8Q34765518-4EDE4811-33A1-4671-B96B-62C586A45943Q34942815-86A61BB6-4AA3-4ACE-844D-10C83061896DQ35061908-3D5463D0-3845-4218-BF10-283095EB2099Q35126638-2439BFBD-E95B-484A-AC78-EBBD1CBA18D8Q35169373-7CEACCB6-0BD4-4D19-A3D9-761A92B61678Q35854142-DB79DB76-C2B6-4B5C-A1D3-D624CAB00714Q35971216-262F1AF7-0F5E-4933-BBCC-5950D832F9AEQ36011919-BE561EF4-B1BB-41C6-A3D1-1A2B0C6A3F07Q36585280-46D2A331-9149-4EB1-B362-88684D37C693Q36694821-DA8E9CD6-61AC-4156-B99F-234FD67E4648Q37043515-2A271803-15DD-4F3F-AE0C-820D610FFBCFQ37050079-DC8AC3FA-A6BD-4B14-8E2F-C47C49D603A1Q37186111-AC9C5419-5DCB-4A0B-A58F-B298A74B70A0Q37277874-1D35353B-27C0-4F2A-A1C8-25237142CCABQ37583220-33C967EA-3CB9-469A-A57B-307FD478AF61Q38071935-D299C399-823B-4EC6-A2CC-DA71E43D1EC1Q39404643-2E0D75E0-D666-40AA-9293-B61844A13337Q41412291-7F8B333F-BC01-45B1-B8E0-A8B03D84B7E2Q43039490-208C6CE6-65C3-4290-8F5B-04D70E0EC770Q43671252-0B84ECD1-9388-45B2-B39B-865D9D573A73Q44900576-570947DE-FFAC-46BA-A12B-BF5B1CFD4BC3Q45215928-A0185626-547A-404B-A9D7-9010C923BB31Q45255356-79BD470F-0C89-4550-93A9-DB15D4A529D0Q45993717-9379337B-377A-4BBB-881E-766095A42155Q46202318-AB56E6E6-3C53-4F4C-9C81-09A81C21BF47Q46584613-0E234213-68AA-493D-A1E0-A25589810D1C
P2860
Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Elevated circulating adiponect ...... altered hepatic hemodynamics.
@en
Elevated circulating adiponect ...... altered hepatic hemodynamics.
@nl
type
label
Elevated circulating adiponect ...... altered hepatic hemodynamics.
@en
Elevated circulating adiponect ...... altered hepatic hemodynamics.
@nl
prefLabel
Elevated circulating adiponect ...... altered hepatic hemodynamics.
@en
Elevated circulating adiponect ...... altered hepatic hemodynamics.
@nl
P2093
P2860
P1476
Elevated circulating adiponect ...... altered hepatic hemodynamics.
@en
P2093
Klaus H W Böker
Matthias J Bahr
Michael P Manns
Uwe J F Tietge
P2860
P356
10.1152/AJPENDO.00494.2003
P577
2004-03-09T00:00:00Z